Kathleen E Koehler, MD | |
364 State Rd, Vineyard Haven, MA 02568-5624 | |
(508) 693-4400 | |
(508) 693-2098 |
Full Name | Kathleen E Koehler |
---|---|
Gender | Female |
Speciality | Internal Medicine |
Experience | 49 Years |
Location | 364 State Rd, Vineyard Haven, Massachusetts |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013967140 | NPI | - | NPPES |
2029341 | Medicaid | MA | |
J04688 | Other | MA | BCBS |
AA6332 | Other | MA | HPHC |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RG0100X | Internal Medicine - Gastroenterology | 49598 (Massachusetts) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Vna Of Cape Cod | Hyannis, MA | Home health agency |
Martha's Vineyard Hospital Inc | Oak bluffs, MA | Hospital |
Falmouth Hospital | Falmouth, MA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Vineyard Medical Care Llc | 7416279591 | 3 |
News Archive
New research from Karolinska Institutet shows that the blood test Stockholm3 together with magnetic resonance imaging and targeted prostate biopsies may lead to a significant decrease in the number of biopsy procedures and diagnoses of harmless disease.
MDCT is a better way to measure annular size in patients with aortic stenosis who are candidates for transcatheter aortic valve implantation than two dimensional echocardiography, a new study indicates.
Plexxikon Inc. today announced promising preclinical data from in vivo cancer studies with PLX3397 demonstrating significant reduction in tumor burden, metastatic spread, bone erosion and cancer bone pain. PLX3397 is an oral, selective kinase inhibitor that down-modulates macrophages, microglia, osteoclasts and mast cells, all cell types targeted by this drug candidate. These cell types play a key role in cancer and metastasis.
At least 80 times in recent years, employees at San Diego County assisted living homes overlooked serious medical issues, gave the wrong medication or otherwise failed to properly care for vulnerable seniors. The problems arose as a result of the unique position held by the care homes, viewed by many families as health-care facilities even though they lack the required levels of training, supervision and oversight. The new cases were examined by U-T Watchdog as part of an ongoing partnership with the CHCF Center for Health Reporting at the University of Southern California (Jeff McDonald, 12/14).
Abiraterone has been approved since September 2011 for men with metastatic prostate cancer that is no longer responsive to hormone therapy and progresses further during or after therapy with the cytostatic drug docetaxel.
› Verified 2 days ago
Entity Name | Vineyard Medical Care Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1346649886 PECOS PAC ID: 7416279591 Enrollment ID: O20141126000953 |
News Archive
New research from Karolinska Institutet shows that the blood test Stockholm3 together with magnetic resonance imaging and targeted prostate biopsies may lead to a significant decrease in the number of biopsy procedures and diagnoses of harmless disease.
MDCT is a better way to measure annular size in patients with aortic stenosis who are candidates for transcatheter aortic valve implantation than two dimensional echocardiography, a new study indicates.
Plexxikon Inc. today announced promising preclinical data from in vivo cancer studies with PLX3397 demonstrating significant reduction in tumor burden, metastatic spread, bone erosion and cancer bone pain. PLX3397 is an oral, selective kinase inhibitor that down-modulates macrophages, microglia, osteoclasts and mast cells, all cell types targeted by this drug candidate. These cell types play a key role in cancer and metastasis.
At least 80 times in recent years, employees at San Diego County assisted living homes overlooked serious medical issues, gave the wrong medication or otherwise failed to properly care for vulnerable seniors. The problems arose as a result of the unique position held by the care homes, viewed by many families as health-care facilities even though they lack the required levels of training, supervision and oversight. The new cases were examined by U-T Watchdog as part of an ongoing partnership with the CHCF Center for Health Reporting at the University of Southern California (Jeff McDonald, 12/14).
Abiraterone has been approved since September 2011 for men with metastatic prostate cancer that is no longer responsive to hormone therapy and progresses further during or after therapy with the cytostatic drug docetaxel.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Kathleen E Koehler, MD 364 State Rd, Vineyard Haven, MA 02568-5624 Ph: (508) 693-4400 | Kathleen E Koehler, MD 364 State Rd, Vineyard Haven, MA 02568-5624 Ph: (508) 693-4400 |
News Archive
New research from Karolinska Institutet shows that the blood test Stockholm3 together with magnetic resonance imaging and targeted prostate biopsies may lead to a significant decrease in the number of biopsy procedures and diagnoses of harmless disease.
MDCT is a better way to measure annular size in patients with aortic stenosis who are candidates for transcatheter aortic valve implantation than two dimensional echocardiography, a new study indicates.
Plexxikon Inc. today announced promising preclinical data from in vivo cancer studies with PLX3397 demonstrating significant reduction in tumor burden, metastatic spread, bone erosion and cancer bone pain. PLX3397 is an oral, selective kinase inhibitor that down-modulates macrophages, microglia, osteoclasts and mast cells, all cell types targeted by this drug candidate. These cell types play a key role in cancer and metastasis.
At least 80 times in recent years, employees at San Diego County assisted living homes overlooked serious medical issues, gave the wrong medication or otherwise failed to properly care for vulnerable seniors. The problems arose as a result of the unique position held by the care homes, viewed by many families as health-care facilities even though they lack the required levels of training, supervision and oversight. The new cases were examined by U-T Watchdog as part of an ongoing partnership with the CHCF Center for Health Reporting at the University of Southern California (Jeff McDonald, 12/14).
Abiraterone has been approved since September 2011 for men with metastatic prostate cancer that is no longer responsive to hormone therapy and progresses further during or after therapy with the cytostatic drug docetaxel.
› Verified 2 days ago
Michael E Jacobs, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 364 State Rd, Vineyard Haven, MA 02568 Phone: 508-693-4400 Fax: 508-693-2098 |